← Leaderboards
Jian Jian Li
Purdue University West Lafayette
$6,553,158
Attributed
$6,553,158
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $705.9K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,553,158 · 5
By mechanism
R01$6,153,158 · 4
R41$400,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- Babak Ziaie$1,138,031
Others in their field
Top investigators on “Radiation”
- Philip J Disaia · University Of California Irvine$135,204,929
- Walter John Curran · Thomas Jefferson University$132,574,833
- Richard L Schilsky · University Of Chicago$122,521,723
- Polly Chang · Sri International$120,948,376
- Maury Tigner · Cornell University$104,613,212
- Norman Wolmark · Nsabp Foundation, Inc.$104,551,329
Research focus
RadiationResistanceCellsMediatingMalignant NeoplasmsPhenotypeCancer TherapyGrowthCancer Stem CellTumor XenograftTumorResponseBreast Cancer CellInsightErbb2 GeneMalignant Breast NeoplasmNeoplastic CellCancer PatientMolecularIn VivoRadiation TherapyDoseNf-Kappa BPathway Interactions
Grant awards (21)
A decellularized porcine placenta matrix hydrogel for management of radiation-induced proctitis$400,000
R41 · FY2023 · CA · contact PI
Mitochondrial bioenergetics is associated with aggressive breast cancer growth$359,138
R01 · FY2021 · CA · contact PI
Mitochondrial bioenergetics is associated with aggressive breast cancer growth$359,138
R01 · FY2020 · CA · contact PI
Mitochondrial bioenergetics is associated with aggressive breast cancer growth$348,363
R01 · FY2019 · CA · contact PI
Mitochondrial bioenergetics is associated with aggressive breast cancer growth$359,138
R01 · FY2018 · CA · contact PI
Mitochondrial bioenergetics is associated with aggressive breast cancer growth$359,138
R01 · FY2017 · CA · contact PI
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells$364,453
R01 · FY2015 · CA · contact PI
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells$361,285
R01 · FY2014 · CA · contact PI
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells$354,376
R01 · FY2013 · CA · contact PI
NF-kB-mediated HER-2 overexpression in radioresistant breast cancer stem cells?$283,888
R01 · FY2013 · CA · contact PI
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells$388,601
R01 · FY2012 · CA · contact PI
NF-kB-mediated HER-2 overexpression in radioresistant breast cancer stem cells?$302,268
R01 · FY2012 · CA · contact PI
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells$400,444
R01 · FY2011 · CA · contact PI
NF-kB-mediated HER-2 overexpression in radioresistant breast cancer stem cells?$305,497
R01 · FY2011 · CA · contact PI
NF-kB-mediated HER-2 overexpression in radioresistant breast cancer stem cells?$313,970
R01 · FY2010 · CA · contact PI
NF-kB-mediated HER-2 overexpression in radioresistant breast cancer stem cells?$308,134
R01 · FY2009 · CA · contact PI
Role of MnSOD in Acquired Resistance to Cancer Therapy$191,334
R01 · FY2008 · CA · contact PI
Role of MnSOD in Acquired Resistance to Cancer Therapy$191,538
R01 · FY2007 · CA · contact PI
Role of MnSOD in Acqired Resistance to Cancer Therapy$197,455
R01 · FY2006 · CA · contact PI
Role of MnSOD in Acquired Resistance to Cancer Therapy$202,392
R01 · FY2005 · CA
Role of MnSOD in Acqired Resistance to Cancer Therapy$202,608
R01 · FY2004 · CA